tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LXEO Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
2d ago
CPRX
DOMH
Lexeo Therapeutics price target lowered to $18 from $19 at Leerink
PremiumThe Fly
Lexeo Therapeutics price target lowered to $18 from $19 at Leerink
2d ago
LXEO
Lexeo Therapeutics price target lowered to $20 from $24 at RBC Capital
PremiumThe Fly
Lexeo Therapeutics price target lowered to $20 from $24 at RBC Capital
2d ago
LXEO
Lexeo Therapeutics Advances Genetic Medicine Initiatives
PremiumCompany Announcements
Lexeo Therapeutics Advances Genetic Medicine Initiatives
3d ago
LXEO
Lexeo Therapeutics reports Q4 EPS (78c), consensus (78c)
PremiumThe Fly
Lexeo Therapeutics reports Q4 EPS (78c), consensus (78c)
4d ago
LXEO
Lexeo Therapeutics sees cash runway into 2027
PremiumThe FlyLexeo Therapeutics sees cash runway into 2027
4d ago
LXEO
LXEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
LXEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
13d ago
LXEO
Lexeo Therapeutics Appoints Dr. Kyle Rasbach as CFO
Premium
Company Announcements
Lexeo Therapeutics Appoints Dr. Kyle Rasbach as CFO
3M ago
8K
LXEO
Lexeo Therapeutics appoints Rasbach as Chief Financial Officer
PremiumThe Fly
Lexeo Therapeutics appoints Rasbach as Chief Financial Officer
3M ago
LXEO
ZNTL
Lexeo Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Lexeo Therapeutics files $300M mixed securities shelf
3M ago
LXEO
Four new option listings and one option delisting on December 10th
PremiumThe Fly
Four new option listings and one option delisting on December 10th
4M ago
TCS
INGM
Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report
PremiumCompany Announcements
Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report
4M ago
LXEO
Lexeo Therapeutics price target raised to $23 from $21 at H.C. Wainwright
PremiumThe FlyLexeo Therapeutics price target raised to $23 from $21 at H.C. Wainwright
4M ago
LXEO
Lexeo Therapeutics price target raised to $25 from $23 at Chardan
Premium
The Fly
Lexeo Therapeutics price target raised to $25 from $23 at Chardan
4M ago
LXEO
Lexeo Therapeutics price target lowered to $19 from $20 at Leerink
Premium
The Fly
Lexeo Therapeutics price target lowered to $19 from $20 at Leerink
4M ago
LXEO
Lexeo Therapeutics Strengthens Leadership with New Board Appointment
PremiumCompany Announcements
Lexeo Therapeutics Strengthens Leadership with New Board Appointment
4M ago
8K
LXEO
Lexeo Therapeutics reaches FDA alignment on development plan for LX2006
PremiumThe Fly
Lexeo Therapeutics reaches FDA alignment on development plan for LX2006
4M ago
LXEO
Lexeo Therapeutics reports Q3 EPS (89c), consensus (68c)
PremiumThe Fly
Lexeo Therapeutics reports Q3 EPS (89c), consensus (68c)
4M ago
LXEO
Lexeo Therapeutics sees cash runway into 2027
PremiumThe Fly
Lexeo Therapeutics sees cash runway into 2027
4M ago
LXEO
Lexeo Therapeutics announces positive results from Phase 1/2 study of LX1001
PremiumThe FlyLexeo Therapeutics announces positive results from Phase 1/2 study of LX1001
5M ago
LXEO
Lexeo Therapeutics to present interim data from Phase 1/2 trial of LX1001
Premium
The Fly
Lexeo Therapeutics to present interim data from Phase 1/2 trial of LX1001
5M ago
LXEO
Lexeo Therapeutics price target lowered to $21 from $22 at H.C. Wainwright
Premium
The Fly
Lexeo Therapeutics price target lowered to $21 from $22 at H.C. Wainwright
8M ago
LXEO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >